Clinical Trial Update: Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing clopidogrel vs aspirin for cardiovascular risk reduction in patients with Staphylococcus aureus infections; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bloodstream Infection
• Staphylococcus Aureus Endocarditis
• Staphylococcus Aureus Septicemia

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Todd C. Lee MD MPH FIDSA | Conditions: Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia | Phase 4 | Status: RECRUITING